Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Miguel Ángel Rodríguez-Milla"'
Autor:
Alvaro Morales-Molina, Miguel Ángel Rodríguez-Milla, Alicia Gimenez-Sanchez, Ana Judith Perisé-Barrios, Javier García-Castro
Publikováno v:
Cancers, Vol 12, Iss 7, p 1920 (2020)
Oncolytic virotherapy uses viruses designed to selectively replicate in cancer cells. An alternative to intratumoral administration is to use mesenchymal stem cells (MSCs) to transport the oncolytic viruses to the tumor site. Following this strategy,
Externí odkaz:
https://doaj.org/article/7a14f0b0e6424d9b9c43bedcedb1f37e
Autor:
Beatriz Martín-Antonio, Belén Blanco, África González-Murillo, Laura Hidalgo, Jordi Minguillón, Gema Pérez-Chacón, Next Generation CART MAD Consortium, Lucía Fernández, Halin Bareke, Andrés París-Muñoz, Adriana Mañas, Cristina Aguirre-Portolés, Alfonso Navarro-Zapata, Carmen Mestre-Durán, Marta Ibáñez-Navarro, Laura Clares-Villa, Sara Naharro, Antonio Perez-Martinez, Marcos Aldea, María Gaibar, Javier Ruiz-Navarro, Manuel Izquierdo, Juan M. Zapata, África González Murillo, Elena García Sánchez, Jorge García Martínez, Alba Rubio San Simón, Blanca Herrero, Gonzalo García Aguilera, Beatriz Horcajo Morera, Manuel Ramírez Orellana, Belén Blanco-Durango, Anais Jiménez-Reinoso, Rodrigo Lázaro-Gorines, Ivana Zagorac, Antonio Tapia Galisteo, Ángel Ramirez-Fernández, Laura Díez-Alonso, Carmen Dominguez-Alonso, Ainhoa Erce-Llamazares, Oana Hangiu, Laura Rubio Pérez, Marina Gómez Rosel, Alejandro Segura Tudela, Javier Arroyo-Ródena, Luis Álvarez-Vallina, Miguel Ángel Rodríguez Milla, Patricia García Rodríguez, Beatriz Somovilla Crespo, Javier García-Castro, Esperanza Esquinas Tarifa, Juana Serrano-López, Pilar Llamas-Sillero, Beatriz Martin-Antonio
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Adoptive T cellular immunotherapies have emerged as relevant approaches for treating cancer patients who have relapsed or become refractory (R/R) to traditional cancer treatments. Chimeric antigen receptor (CAR) T-cell therapy has improved survival i
Externí odkaz:
https://doaj.org/article/49d95b3c222f4b7389eb0625d73c49df
Autor:
Miguel Ángel Rodríguez-Milla, Ana Judith Perisé-Barrios, Alvaro Morales-Molina, Javier García-Castro, Teresa Cejalvo
Publikováno v:
Cancer Gene Therapy. 28:64-73
Factor de impacto: 5,987 Q1 There is increasing evidence about the use of oncolytic adenoviruses (Ads) as promising immunotherapy agents. We have previously demonstrated the clinical efficiency of mesenchymal stem cells (MSCs) infected with oncolytic
Autor:
Javier García-Castro, Ana Judith Perisé-Barrios, Alvaro Morales-Molina, Alicia Gimenez-Sanchez, Miguel Ángel Rodríguez-Milla
Publikováno v:
Repisalud
Instituto de Salud Carlos III (ISCIII)
Cancers
Volume 12
Issue 7
Cancers, Vol 12, Iss 1920, p 1920 (2020)
Instituto de Salud Carlos III (ISCIII)
Cancers
Volume 12
Issue 7
Cancers, Vol 12, Iss 1920, p 1920 (2020)
Oncolytic virotherapy uses viruses designed to selectively replicate in cancer cells. An alternative to intratumoral administration is to use mesenchymal stem cells (MSCs) to transport the oncolytic viruses to the tumor site. Following this strategy,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a44d320e6ca80a91c7eb478c509d0de4
https://hdl.handle.net/20.500.12105/10846
https://hdl.handle.net/20.500.12105/10846
Autor:
Gisèle Bonne, Anne Bertrand, Carolina Epifano, Javier Ramón-Azcón, Alberto Martín, Albert G. Castaño, Miguel Ángel Rodríguez-Milla, Déborah Gómez-Domínguez, Fernando de Miguel, Borja Vilaplana-Martí, Sandra Amarilla-Quintana, Ignacio Pérez de Castro
Publikováno v:
Cells
Repisalud
Instituto de Salud Carlos III (ISCIII)
Cells, MDPI, 2020, 9 (5), pp.1286. ⟨10.3390/cells9051286⟩
Cells, Vol 9, Iss 1286, p 1286 (2020)
ABACUS. Repositorio de Producción Científica
Universidad Europea (UEM)
Volume 9
Issue 5
Repisalud
Instituto de Salud Carlos III (ISCIII)
Cells, MDPI, 2020, 9 (5), pp.1286. ⟨10.3390/cells9051286⟩
Cells, Vol 9, Iss 1286, p 1286 (2020)
ABACUS. Repositorio de Producción Científica
Universidad Europea (UEM)
Volume 9
Issue 5
Laminopathies are causally associated with mutations on the Lamin A/C gene (LMNA). To date, more than 400 mutations in LMNA have been reported in patients. These mutations are widely distributed throughout the entire gene and are associated with a wi
Autor:
Ana Judith Perisé-Barrios, Miguel Ángel Rodríguez-Milla, Stefano Gambera, Javier García-Castro, Alvaro Morales-Molina, Teresa Cejalvo, Rafael Moreno
Publikováno v:
Repisalud
Instituto de Salud Carlos III (ISCIII)
Instituto de Salud Carlos III (ISCIII)
Factor de impacto: 6,968 Q1 Oncolytic virotherapy uses oncolytic viruses that selectively replicate in cancer cells. The use of cellular vehicles with migration ability to tumors has been considered to increase their delivery to target sites. Followi
Autor:
Francisca Mulero, Rene Rodriguez, Ander Abarrategi, Miguel Ángel Rodríguez-Milla, Stefano Gambera, Javier García-Castro, Sofía T. Menéndez, Samuel Navarro
Publikováno v:
Scopus
RUO. Repositorio Institucional de la Universidad de Oviedo
instname
STEM CELLS
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
RUO. Repositorio Institucional de la Universidad de Oviedo
instname
STEM CELLS
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
Osteosarcoma (OS) is a highly aggressive bone tumor that usually arises intramedullary at the extremities of long bones. Due to the fact that the peak of incidence is in the growth spurt of adolescence, the specific anatomical location, and the heter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e800ab81ca7ad765680d3b10b4c4c81e
http://hdl.handle.net/10651/49920
http://hdl.handle.net/10651/49920
Autor:
Francisca Mulero, Probir Chakravarty, Alexander Waclawiczek, Raquel Pérez-Tavarez, Miguel Ángel Rodríguez-Milla, Ander Abarrategi, Stefano Gambera, Kevin Rouault-Pierre, Javier García-Castro, Arantzazu Alfranca, Cesar Trigueros, Samuel Navarro, Dominique Bonnet
Publikováno v:
Scientific Reports
Scientific Reports, Vol 8, Iss 1, Pp 1-13 (2018)
Repisalud
Instituto de Salud Carlos III (ISCIII)
Scientific Reports, Vol 8, Iss 1, Pp 1-13 (2018)
Repisalud
Instituto de Salud Carlos III (ISCIII)
Mesenchymal progenitor cells (MPCs) have been hypothesized as cells of origin for sarcomas, and c-Fos transcription factor has been showed to act as an oncogene in bone tumors. In this study, we show c-Fos is present in most sarcomas with chondral ph
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc78b1ec261665bb94fa3689bb69d0cf
https://hdl.handle.net/20.500.12105/9136
https://hdl.handle.net/20.500.12105/9136
Autor:
Noemí del Castillo, Eduardo Laborda, Ramon Alemany, Isabel Cubillo, Fernando León Vázquez, Manuel Ramírez, Miguel Ángel Rodríguez-Milla, Javier García-Castro, David Sardón, Isabel del Portillo, Ana Judith Perisé-Barrios, Teresa Cejalvo
Publikováno v:
Repisalud
Instituto de Salud Carlos III (ISCIII)
Instituto de Salud Carlos III (ISCIII)
Dogs with spontaneous tumors treated in veterinary hospitals offer an excellent opportunity for studying immunotherapies, including oncolytic viruses. Oncolytic viruses have advanced into the clinic as an intratumorally administered therapeutic; howe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3dfa2339ab18889c865572895e26e097
http://hdl.handle.net/20.500.12105/10620
http://hdl.handle.net/20.500.12105/10620
Autor:
Miguel Ángel Rodríguez-Milla, María Vallet-Regí, Marina Martínez-Carmona, Alejandro Baeza, Javier García-Castro
Publikováno v:
E-Prints Complutense: Archivo Institucional de la UCM
Universidad Complutense de Madrid
E-Prints Complutense. Archivo Institucional de la UCM
instname
Universidad Complutense de Madrid
E-Prints Complutense. Archivo Institucional de la UCM
instname
A novel phototriggered drug delivery nanocarrier, which exhibits very high tumor cytotoxicity against human tumoral cells, is presented. This device is based on mesoporous silica nanoparticles decorated with a biocompatible protein shell cleavable by